IGC Pharma, Inc. (IGC): Capital Expenditures

Annual figures by period end, from SEC filings.

Not updated since 2025-03-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-03-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$112.0K
Year ended 2025-03-31
$82.0K
Trailing 12 months to 2025-09-30
-22.0%
3-year compound annual growth
$4.39M2011-03-31: $285.4K2012-03-31: $5.5K2013-03-31: $326.1K2014-03-31: $8.5K2015-03-31: $76.5K2016-03-31: $122.2K2017-03-31: $145.7K2018-03-31: $136.0K2019-03-31: $15.0K2020-03-31: $4.39M2021-03-31: $1.47M2022-03-31: $236.0K2023-03-31: $310.0K2024-03-31: $138.0K2025-03-31: $112.0K$112.0K
2011-03-31 Capital Expenditures (USD) 2025-03-31
Period endedCapital ExpendituresChange YoYSource filing
2025-03-31$112.0K-18.8%2025-06-27, From 2024-04-01
2024-03-31$138.0K-55.5%2025-06-27, From 2023-04-01
2023-03-31$310.0K+31.4%2024-06-24, From 2022-04-01
2022-03-31$236.0Kn/c2023-07-07, From 2021-04-01
2021-03-31$1.47M-66.5%2022-06-23, From 2020-04-01
2020-03-31$4.39Mn/m2021-06-14, From 2019-04-01
2019-03-31$15.0K-89.0%2020-07-13, From 2018-04-01
2018-03-31$136.0K-6.6%2019-06-14, From 2017-04-01
2017-03-31$145.7K+19.2%2018-06-21, From 2016-04-01
2016-03-31$122.2K+59.7%2017-07-14, From 2015-04-01
2015-03-31$76.5K+801.9%2016-07-14, From 2014-04-01
2014-03-31$8.5K-97.4%2015-07-14, From 2013-04-01
2013-03-31$326.1Kn/m2014-07-15, From 2012-04-01
2012-03-31$5.5K-98.1%2014-07-15, From 2011-04-01
2011-03-31$285.4Kn/a2012-07-16, From 2010-04-01